← Back to Patent Explorer
US5777099A Expired / Lapsed US ⏱️ 0.0 years remaining

RNA separation

Assignee: Biotecx Laboratories Inc
•
Filing: 1996-09-04
•
Granted: 1998-07-07
•
Expires: 2016-09-04
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An improved process for the separation of RNA from a liquid sample of biological origin containing RNA comprises (a) intimately contacting the sample with a two-phase composition wherein the upper phase is predominately phenol and the lower phase is an aqueous solution comprising at least one water-soluble guanidinium salt, a buffer and urea, the water content of the aqueous phase being relatively low, (b) adding a relatively dense water-insoluble solvent and (c) recovering RNA from the resulting aqueous phase.

Inventors

  • 👤 Manmohan Mehra

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 10:35
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/10; C12N15/1003

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 103 words
In the process of separating RNA from biological samples containing RNA by contacting the sample with a two-phase composition wherein the upper phase is predominately phenol and the lower phase is an aqueous solution containing at least one water-soluble guanidinium salt, a buffer and urea, the improvement which comprises separating RNA from a substantially liquid biological sample with the two-phase composition wherein the phenol is present in a quantity not more than about 40% by weight based on total composition and the water is present in a quantity from about 10% by weight to about 25% by weight, inclusive, based on total composition.
Claim 2
Dependent Claim 103 words
In the process of separating RNA from biological samples containing RNA by contacting the sample with a two-phase composition wherein the upper phase is predominately phenol and the lower phase is an aqueous solution containing at least one water-soluble guanidinium salt, a buffer and urea, the improvement which comprises separating RNA from a substantially liquid biological sample with the two-phase composition wherein the phenol is present in a quantity not more than about 40% by weight based on total composition and the water is present in a quantity from about 10% by weight to about 25% by weight, inclusive, based on total composition.
Claim 3
Dependent Claim 13 words
The process of claim 1 wherein the substantially liquid sample is blood serum.
Claim 4
Dependent Claim 28 words
The process of claim 2 wherein the phenol is present in a quantity from about 30% by weight to about 38% by weight, inclusive, based on total composition.
Claim 5
Dependent Claim 28 words
The process of claim 3 wherein the water is present in a quantity from about 15% by weight to about 23% by weight, inclusive, based on total composition.
Claim 6
Dependent Claim 80 words
A two-phase liquid composition wherein the upper phase is predominately phenol and the lower phase is an aqueous solution of at least one water-soluble guanidinium salt, a buffer and urea, the phenol is present in a quantity of from about 30% by weight to about 38% by weight, inclusive, based on total composition, and the water of the aqueous phase is present in a quantity from about 10% by weight to about 25% by weight, inclusive, based on total composition.
Claim 7
Dependent Claim 80 words
A two-phase liquid composition wherein the upper phase is predominately phenol and the lower phase is an aqueous solution of at least one water-soluble guanidinium salt, a buffer and urea, the phenol is present in a quantity of from about 30% by weight to about 38% by weight, inclusive, based on total composition, and the water of the aqueous phase is present in a quantity from about 10% by weight to about 25% by weight, inclusive, based on total composition.
Claim 8
Dependent Claim 43 words
The composition of claim 5 wherein the at least one water-soluble guanidinium salt is at least one of guanidinium thiocyanate and guanidinium chloride in a total amount of from about 15% by weight to about 25% by weight, inclusive, based on total composition.
Claim 9
Dependent Claim 18 words
The composition of claim 6 wherein the buffer is an alkali metal salt of a weak organic acid.
Claim 10
Dependent Claim 24 words
The composition of claim 7 wherein the alkali metal moiety is sodium and the organic acid is citric acid, acetic acid or tartaric acid.
Claim 11
Dependent Claim 11 words
The composition of claim 8 wherein the buffer is sodium citrate.
Claim 12
Dependent Claim 28 words
The composition of claim 7 wherein the urea is present in a quantity of from about 5% by weight to about 15% by weight, based on total composition.
Claim 13
Dependent Claim 17 words
The composition of claim 10 wherein the predominately phenol phase is at least 98% by weight phenol.
Claim 14
Dependent Claim 33 words
The composition of claim 10 wherein the water of the aqueous phase is present in a quantity of from about 15% by weight to about 23% by weight, inclusive, based on total composition.
Claim 15
Dependent Claim 70 words
A process of separating RNA from a liquid sample of biological origin containing RNA which comprises intimately contacting the sample with the composition of claim 4, adding to the resulting mixture a water-insoluble solvent, thereby forming an aqueous phase containing RNA and an organic phase containing other components of the liquid sample, separating the aqueous phase containing RNA from the remaining mixture, and recovering the RNA from the aqueous phase.
Claim 16
Dependent Claim 14 words
The process of claim 13 wherein the liquid sample of biological origin is serum.
Claim 17
Dependent Claim 11 words
The process of claim 14 wherein the serum is blood serum.

References Cited (Backward Citations)

US3389133A Cited
US4830969A Cited
US4843155A Cited
US5234809A Cited
US5130423A Cited
US5393672A Cited
US5422241A Cited
EP0554034A1 Cited
US5346994A Cited
US5300635A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2001-07-06 2002-01-05 2002-07-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2005-07-06 2006-01-05 2006-07-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2009-07-06 2010-01-05 2010-07-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag